Learn

Learn About Refractory Depression on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Refractory Depression on CME Webcast. We now have additional treatments for resistant depression that are expanding the therapeutic options for these patients. And we’re going to hear about these treatments in today’s webcast. Let us welcome our guests. Dr. Subhdeep Virk is an Associate Professor of Psychiatry at the Ohio State University. And Dr. Kevin Reeves is an Assistant Professor of Psychiatry here at OSU.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define and screen depression and Treatment Resistant Depression; discuss therapeutic options for treating Refractory Depression; become aware of resources to evaluate treatment history; and compare and contrast transcranial magnetic stimulation, electroconvulsive therapy, intranasal esketamine and electroconvulsive therapy.

You’ll also learn about the following:

  • Epidemiology of treatment resistant depression
  • Electroconvulsive therapy today
  • When to refer patients to a psychiatrist?
  • When to admit patients

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Advance Care Planning on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Advance Care Planning on CME Webcast. We have come a long way in the evolution of advance directives but it is still common for patients, physicians, and families to be faced with having to make a sudden decision about whether to institute life-saving measures. Particularly because sometimes those measures do less to prolong life than to prolong the process of death. Joining us today to help all of us become better at proactively discussing advance directives with our patients is palliative medicine specialist and Assistant Professor of Internal Medicine, Dr. Kavitha Norton.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define Advance Care Planning as Communication Process for Patient Empowerment; and discuss components and products of Advance Care Planning including proxy and health documents.

You’ll also learn about the following:

  • DNR, DNR-CCA, & DNR-CC
  • Starting the advance care directive discussion
  • Common definition of Advance Care Planning & Framework
  • Challenges with Advance Care Planning
  • Tools and resources for these discussions
  • Documenting

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Cardiac Non-Invasive Testing On Webcast

by

OSUWexnerbloglogo2014 Learn About Cardiac Non-Invasive Testing On Webcast. Today on MedNet21, we are going to update you on the currently used tests to non-invasively identify patients with ischemic heart disease. To tell us about stress test options, we’re pleased to welcome cardiologist and Assistant Professor of Internal Medicine Dr. Bryan Lee. And then to tell us about the role of cardiac CT and MRI, we have cardiologist and Assistant Professor of Internal Medicine, Dr. Salman Bhatti.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe how to assess the pre-test likelihood of coronary artery disease by history; and understand the advantages and pitfalls between the different modalities; recognize when it is appropriate to order a stress test; and understand how different stress modalities compare with each other, their advantages and disadvantages and when to use one over the other.

You’ll also learn about the following:

  • Cardiac stress test selection
  • Cardiac CT & MRI
  • Common indications for cardiac MRI
  • Training required to read cardiac CT & MRI

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Lymphadenopathy and New Treatments for Lymphoproliferative Disorders

by

OSUWexnerbloglogo2014 Learn About Lymphadenopathy and New Treatments for Lymphoproliferative Disorders. Today on MedNet21, we are going to bring you up to date on the approach to lymphadenopathy and then tell you about some exciting new treatments for lymphoma that are changing the management of the disease. Our guests today are hematologist and Assistant Professor of Internal medicine, Dr. David Bond. And also Assistant Professor of Internal Medicine from the Division of Hematology, Dr. Yazeed Sawalha.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: review the mechanisms
of action and clinical data of (CAR) T cells and BiTEs in patients with relapsed/refractory B-cell non-Hodgkin lymphoma; highlight unique toxicities associated with CAR T cells and BiTEs: cytokines release syndrome and neurotoxicity; recognize the leading differential diagnosis considerations for a patient presenting with undifferentiated lymphadenopathy; and Differentiate diagnostic biopsy approaches including fine needle aspiration, core needle biopsy, and excisional lymph node biopsy.

You’ll also learn about the following:

  • New treatments for lymphoma
  • Cost and insurance coverage for CAR T-cells and bispecific T-cell engagers
  • What patients should expect during treatment
  • Stem cell transplant timing
  • Stem cell transplant versus bone marrow transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease

by

OSUWexnerbloglogo2014 Webcast Helps Physicians Learn About Ocular Complications of Systemic Disease. It has been said that the eyes are the windows to the soul. That may or may not be true but the eyes can be the windows to disease. Sometimes, it is the ocular findings that are the first clue to an underlying systemic disease. Other times, a known systemic disease may alert the physician about the risks of important ocular complications. The ophthalmoscope allows you to examine structures you can’t otherwise see. For example, the retinal arteries are the only arteries that are easily visible non-invasively. Today on MedNet21, we’re going to see how the eye can be affected by many common systemic diseases. My guest is Assistant Professor of Ophthalmology, Dr. Carla Ford.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: discuss ocular findings
of common systemic diseases; and provide a brief overview of treatment options of ocular complications of systemic diseases.

You’ll also learn about the following:

  • Common systemic diseases affecting the eye
  • Central retinal vein occlusion
  • Migraine and the eye
  • Candidemia
  • HIV and the eye

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.